Second-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer (Q46562163)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 2008

edit

Language	Label	Description	Also known as
English	Second-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer	scientific article published in June 2008

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18520300

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/18520300

review article

1 reference

stated in

Europe PubMed Central

title

Second-generation epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18520300

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/18520300

author name string

Gregory J Riely

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18520300

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/18520300

publication date

1 June 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18520300

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/18520300

published in

Journal of Thoracic Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18520300

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/18520300

volume

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18520300

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/18520300

issue

6 Suppl 2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18520300

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/18520300

page(s)

S146-9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18520300

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/18520300

cites work

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

1 reference

stated in

COCI

retrieved

24 May 2022

reference URL

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1141478

Identifiers

DOI

10.1097/JTO.0B013E318174E96E

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18520300

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/18520300

PubMed publication ID

18520300

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18520300

retrieved

23 December 2017

reference URL

http://europepmc.org/abstract/MED/18520300

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46562163&oldid=2118458668"